Ionis Pharmaceuticals reported $2.99B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Adcock Ingram Holdings ZAR 8.74B 388.13M Dec/2024
Agios Pharmaceuticals USD 1.47B 84.28M Jun/2025
Alnylam Pharmaceuticals USD 4.57B 352.21M Jun/2025
Arrowhead Research USD 1.38B 192.89M Jun/2025
Astellas Pharma JPY 3.34T 3.71B Jun/2025
BioMarin Pharmaceutical USD 7.46B 309.33M Jun/2025
Celltrion KRW 20.96T 96.41B Mar/2025
Cspc Pharmaceutical CNY 44.39B 3.51B Dec/2024
Divis Laboratories Ltd 169.32B 13.46B Mar/2025
Exelixis USD 2.68B 159.17M Jul/2025
Halozyme Therapeutics USD 2.05B 142.63M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
Kangmei Pharma CNY 13.64B 69.1M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 869.6M 37.58M Jun/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 65.33M 6.17M Dec/2024
Moderna USD 12.01B 694M Jun/2025
Neuren Pharmaceuticals AUD 409.71M 181.55M Dec/2024
Neurocrine Biosciences USD 3.89B 202.1M Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
OPKO Health USD 1.97B 227.21M Jun/2025
Organigram Holdings CAD 564.62M 85.41M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Pharma Mar EUR 348.25M 14.75M Jun/2025
PTC Therapeutics USD 2.63B 21.23M Jun/2025
Qiagen NV USD 5.82B 278.39M Jun/2025
Regeneron Pharmaceuticals USD 38.22B 674M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sarepta Therapeutics USD 3.68B 214.43M Jun/2025
Sartorius EUR 10.03B 85.1M Jun/2025
Sino Biopharmaceutical CNY 65.41B 1.3B Dec/2024
Tilray USD 4.19B 70.11M Nov/2024
Ultragenyx Pharmaceutical USD 1.31B 5.66M Jun/2025
Vertex Pharmaceuticals USD 24.04B 1.16B Jun/2025
Zz Pientze Pharmaceu 18.71B 224.21M Jun/2025